Wegovy Cut Children's BMI by 17.4% in Novo's Late-Stage Trial
Wegovy cut BMI 17.4% in children ages 6 to under 12 over 68 weeks, Novo's full trial results show, with over 40% no longer classified as having obesity — a group with no approved obesity drugs today.
